Table 1.
1. Caused by complement protein mutations: atypical hemolytic uremic syndrome |
2. De novo post-transplant associated TMA or secondary aHUS a. Related to the type of donor and the organ procurement - Complement activation associated to DBD and CDC - Ischemia reperfusion injury b. Associated to post-transplant events - Drugs - Calcineurin inhibitors - mTOR inhibitors - ABMR - Infection - Viral: CMV, parvovirus, Nile fever - Funghi Antiphospholipid syndrome c. Other causes of TMA not related to the kidney transplant: malignancies, pregnancy, other drugs (anti VEGF, gemcitabine,…) |
DBD, donor after brain death; DCD, donor after cardiocirculatory death; ABMR, antibody mediated rejection; CMV, cytomegalovirus.